Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. Exactly a month after it announced the removal of black box warning labels on estrogen therapy products ...
Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance. Like previous FDA expert panels, the ...
Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs Administration hosted an expert panel to discuss the other ...
The House Foreign Affairs Committee advanced legislation Wednesday requiring US President Donald Trump to designate the Muslim Brotherhood as a terrorist organization, JNS reported. The bipartisan ...
MKBHD is shutting down the Panels app at the end of this month, citing issues with finding the right development team fit. You can no longer buy collections, and you ...
CommScope delivered strong Q3 results, with the CCS segment outperforming and contributing significant cash flow ahead of its sale to Amphenol. RemainCo's earnings show cyclical patterns but ...
CommScope’s Ruckus Networks introduced an AI-driven operations platform and a pair of Wi-Fi 7 access points aimed at the expanding multidwelling unit (MDU) market. The new MDU Suite is designed to ...
CommScope Holding Company has rebounded from a debt crisis by divesting key business units, notably selling CCS to Amphenol for $10.5bn. With the divestitures, COMM will repay all debt, redeem ...
Labels, particularly when applied to human beings and their behavior, can have a surprisingly polarizing effect, regardless of the label’s efficacy. Some people resist labels altogether, while others ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
CommScope Holding Co. reached a deal to sell its broadband and cable equipment arm to Amphenol Corp. for about $10.5 billion in cash, the second such deal it’s done with Amphenol as part of a series ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results